Analysed Cadrenal Therapeutics Inc (CVKD:NASDAQ) News Sources
Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement
Yahoo Finance
Cadrenal Therapeutics Inc.: Cadrenal Therapeutics Announces Phase 2 Results with Encouraging Reductions in Thrombotic Events for CAD-1005 in HIT, Supporting Clinical Advancement
FinanzNachrichten.de
CVKD: Acquires 12-LOX Inhibitor for the Treatment of Heparin-Induced Thrombocytopenia (HIT)
Yahoo Finance
What is the current price of Cadrenal Therapeutics Inc (CVKD:NASDAQ)?
The current price of Cadrenal Therapeutics Inc (CVKD:NASDAQ) is $8.0.
Cadrenal Therapeutics Inc (CVKD:NASDAQ) absolute price change since previous trading day?
The absolute price change of Cadrenal Therapeutics Inc (CVKD:NASDAQ) since the previous trading day is $0.21.
Cadrenal Therapeutics Inc (CVKD:NASDAQ) percentage price change since previous trading day?
The percentage price change of Cadrenal Therapeutics Inc (CVKD:NASDAQ) since the previous trading day is 2.70%.
What is This Week's average sentiment score for Cadrenal Therapeutics Inc (CVKD:NASDAQ)?
This Week's average sentiment score for Cadrenal Therapeutics Inc (CVKD:NASDAQ) is 84 out of 100.
What is This Week's average sentiment for Cadrenal Therapeutics Inc (CVKD:NASDAQ)?
This Week's sentiment for Cadrenal Therapeutics Inc (CVKD:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.